Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Former U.S. FDA Official Says Congress Should Fix China API Problem

This article was originally published in PharmAsia News

Executive Summary

As far back as 1999, U.S. Congress pressed U.S. FDA to deal more effectively with a China-made drug believed to be contaminated and responsible for 17 deaths. In that case, an antibiotic was involved, but today Congress again is investigating why FDA was so late in becoming aware of the link between 19 deaths and a contaminated heparin ingredient produced in China. Former FDA Deputy Commissioner William Hubbard noted the similarities and said the incidents would be repeated "until Congress fixes this problem." (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067925

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel